HCS
VRTX icon

Himension Capital (Singapore)’s Vertex Pharmaceuticals VRTX Stock Holding History

Himension Capital (Singapore)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$471K Buy
+949
New +$421K 0.03% 146
2023
Q4 		– Sell
-1,689
Closed -$587K – 94
2023
Q3 		$587K Buy
+1,689
New +$591K 0.06% 40

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Himension Capital (Singapore)'s VRTX Position: Q2 2026 in Review

Himension Capital (Singapore) opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 949 shares worth $471K. The stake represents 0.03% of the portfolio and ranks #146 among its holdings. This is a return to the name: Himension Capital (Singapore) previously reported a position in VRTX as recently as Q3 2023.

Himension Capital (Singapore) first reported a position in VRTX in Q3 2023 and has held it in 2 quarters since. The position peaked at $587K in Q3 2023. 1,763 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Himension Capital (Singapore) held 949 shares of Vertex Pharmaceuticals worth $471K as of Q2 2026.
  • Vertex Pharmaceuticals was a new Himension Capital (Singapore) position in Q2 2026.
  • Vertex Pharmaceuticals made up 0.03% of Himension Capital (Singapore)'s portfolio in Q2 2026, its #146 holding.
  • Himension Capital (Singapore) first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 2 quarters since.
  • Himension Capital (Singapore)'s Vertex Pharmaceuticals position peaked at $587K in Q3 2023.
  • 1,763 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Himension Capital (Singapore)'s 13F filing for Q2 2026, filed 13 Aug 2026.